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Abstract The interaction of avian smooth muscle caldesmon 
with calmodulin (CAM) was investigated by studying the ability 
of selected mutant calmodulins to induce fluorescence changes in 
caldesmon. Different types of CaM mutants were used including 
point charge mutants, cluster mutations, and mutations which 
alter the calcium binding of CaM. The caldesmon binding proper- 
ties were only slightly affected by E84K-CaM or by the double 
mutation E84Q/E120Q-CaM. Affinity of calmodulin to cal- 
desmon was decreased 2-4 times by point mutation G33V-CaM, 
double mutation E841(dEI20K-CaM, deletion of residues 82-84, 
and by cluster mutations DEEll8-120-->KKK or EEE82- 
84--~KKK. Mutations of the first (E31A-CaM) and the 
second (E67A-CaM) calcium binding sites reduced the affinity of 
calmodulin to caldesmon by at least 5-fold; in addition these 
calmodulin mutants exhibited smaller changes in the fluorescence 
spectra of caldesmon. Simultaneous mutation of the two nega- 
tively charged clusters of calmodulin EEE82-84--~ KKK and 
DEEll8-120 --> KKK resulted in a more than 15-fold decrease in 
the affinity of calmodulin for caldesmon. The data indicate that 
charged and uncharged amino acids in both halves of CaM play 
an important role in the binding of calmodulin to caldesmon, and 
that Ca 2+ binding must be maintained in the amino-terminal sites 
for maximal interaction with caldesmon. 
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1. Introduction 
Caldesmon is a ubiquitous actin-binding protein which seems 
to be involved in the regulation of smooth muscle and non- 
muscle motility [1-3]. Caldesmon interacts with a number of 
calcium-binding proteins such as calmodulin [1-3], S-100 pro- 
tein [4,5], caltropin [6] and troponin C [7]. Of  all these proteins, 
calmodulin seems to be the most probable regulator of cal- 
desmon function in smooth muscle [1-3]. The carboxyl-termi- 
nal actin- and tropomyosin-binding domain of chicken gizzard 
caldesmon contains at least two calmodulin-binding sites en- 
compassing residues 651-666 and 680-695 [8,9]. Although an 
initial report on the localization of the caldesmon-binding sites 
on calmodulin has appeared in the literature [10], the sites on 
calmodulin that interact with caldesmon are not well character- 
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ized. The structural basis of the binding of calmodulin by cal- 
desmon is poorly understood because it belongs to a group of 
lower affinity calmodulin-binding proteins and may be different 
from that of the well-characterized, high-affinity calmodulin- 
binding proteins such as myosin light chain kinase (MLCK). 
The aim of the current study was to characterize the interaction 
of several calmodulin mutants with caldesmon to obtain infor- 
mation which contributes towards our understanding of the 
mechanism underlying the calmodulin-caldesmon interaction. 
2. Materials and methods 
Duck gizzard caldesmon and bovine brain calmodulin were isolated 
as described earlier [l 1,12]. Site-directed mutagenesis was used to gen- 
erate the various mutant calmodulins [13,14]. The mutations are de- 
scribed in Table 1. Mutants of this series have been referred to by using 
the prefixes 'SYNCAM' or 'VU' [13 15]. All calmodulins were homo- 
geneous as assessed by SDS-gel electrophoresis. The concentration of
caldesmon and bovine brain calmodulin was determined spectro- 
photometrically using E°2~ ° equal to 0.33 and 0.20, respectively [16,17]. 
The concentration f calmodulin mutants was determined by the dye- 
binding method of Spector [18] using bovine brain calmodulin as a 
standard. 
The interaction of caldesmon with calmodulin was determined by 
measuring the calmodulin-induced increase in Trp fluorescence of cal- 
desmon [19-21]. A single concentration (200 nM) of caldesmon was 
used throughout these experiments o allow facile comparison of the 
data derived from several CaM mutants, and avoid problems associated 
with caldesmon self-association [20]. Briefly, 200 nM of caldesmon i  
10 mM Tris-HCl, pH 7.4, containing 100 mM KC1, 0.1 mM CaC12 and 
4.2 mM fl-mercaptoethanol, was titrated with increasing quantities of 
calmodulin. The excitation wavelength was set at 290 nm (xenon lamp, 
slit width 5 nm) and fluorescence measured at 322 nm (slit width 1.5 
nm) on a Hitachi F-3000 spectrofluorimeter. The fluorescence ll (op- 
tical path 1 cm) containing 1ml of caldesmon solution was maintained 
at 26°C by a constant-temperature water bath and illuminated for only 
short periods of time (less than 30 s) for making measurements. Calm- 
odulin was added in small portions by microsyringe, and the total 
volume of solution added was not more than 25 B1. Therefore, the 
dilution caused by calmodulin additions was negligible. In separate 
control experiments he incubation buffer without caldesmon was ti- 
trated with calmodulin, and the fluorescence caused by calmodulin was 
subtracted from the experimental values. Sample fluorescence spectra 
and titration data are shown in Fig. 1. Data were fit to a non-linear 
binding equation: 
F= F° + Fmax" L- -2~N- 
where F0 is the initial caldesmon fluorescence in the absence of calmod- 
ulin added; Fmax is the maximal increase in the fluorescence induced by 
calmodulin; C, total calmodulin concentration; N, total concentration 
of calmodulin binding sites; and K, the apparent dissociation constant, 
K d. F=a ,, N and K can thus be calculated from the fluorescence titration 
data. In all cases we found that Nwas essentially equal to the caldesmon 
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concentration. Therefore, the binding constants (Kd) were calculated 
based upon the binding of 1 mol of CaM per mol of caldesmon [8,20]. 
Under the experimental conditions used, the Ka values for the low 
affinity (Kd > 400 nM) calmodulin mutants can not be determined 
precisely. These data are clearly noted in Table 1. 
3. Results 
Calmodulin itself does not contain Trp residues [17], there- 
fore, following the Trp fluorescence ofcalmodulin-binding pro- 
teins one can obtain information on the interaction ofthe target 
proteins with calmodulin. Indeed titration by Ca2+-saturated 
calmodulin results in a 1.5-1.8 fold increase in tryptophan 
fluorescence of caldesmon accompanied by a 10-15 nm blue 
shift of the fluorescence maximum (from 355 360 nm to 340- 
345 nm) [19-21] (Fig. 1A). These properties make fluorescence 
titration the method of choice for investigation of interaction 
of intact caldesmon and its fragments with calmodulin [8,9,19- 
21]. Under the conditions used, bovine brain calmodulin and 
bacterially expressed calmodulin (VU-1) induced a 1.8-1.9 fold 
increase in Trp fluorescence ofcaldesmon and a significant blue 
shift of the fluorescence maximum (Table 1, Fig. 1A). The 
apparent Kd calculated for the two wild-type calmodulins was 
about 70 nM. These results agree well with the data of Malencik 
et al. [20] obtained under similar conditions. 
The use of CaM mutants for studying the interaction ofCaM 
with target proteins is well documented [13 15,22-24]. Many 
of the mutants have differences in charged amino acids which 
affect heir ability to activate selected CaM-dependent enzymes 
such as MLCK [14,23,24], CaM-dependent protein kinase II 
[14], phosphorylase kinase [15], and plasma membrane Ca 2÷- 
ATPase [22]. In our study of CaM mutants we found that the 
results with the CaM mutants can be divided into three groups, 
as shown in Table 1. The distinction among the groups is based 
upon the relative ffects on caldesmon i teraction, as revealed 
by the fluorescence titrations. The first group includes muta- 
tions which had little or no effect on the CaM-caldesmon 
interaction. These mutants contained single point mutations in
the central helix (E84K-CaM, VU-28) or in the third Ca-bind- 
ing loop (S101F-CaM, VU-17) or a mutant where two nega- 
tively charged residues (Glu-84 and Glu-120) are replaced by 
the neutral Gln residues (VU-65). The group 1 mutants also 
induced significant blue shift of the caldesmon fluorescence 
maximum, similar to wild-type CaMs. 
A second group of CaM mutants (group 2) showed ecreased 
interaction with caldesmon, as evidenced by a 2~, fold increase 
in the Kd values (Table 1). Included in this group are: G33V- 
CaM (VU-5), containing a point mutation flanking the first 
Ca2+-binding site; a deletion mutant (VU-64C), where three Glu 
residues in the central helix have been deleted; and a charge 
cluster mutant (VU-8), where residues 82-84 have been re- 
placed by three Lys residues. These CaMs exhibited about a 
twofold increase in the K d value compared to wild-type CaM. 
The increase in caldesmon fluorescence (Fmax) and degree of 
blue shift produced by these group 2 mutants, however, was 
comparable to that induced by wild-type calmodulin (Table 1). 
On the other hand, changes in Fma X and/or decreased blue shifts 
accompanied the increased K d values of caldesmon i teraction 
with two other group 2 calmodulin mutants, VU-12A and VU- 
40. The latter mutant contains two charge changes (E84K and 
E120K), while VU-12A CaM has the charge cluster, DEE(118- 
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Fig. 1. Interaction of duck gizzard caldesmon with calmodulin mutants. 
(A) Fluorescence spectra of isolated VU-1 CaM (1), VU-60 CaM (2), 
caldesmon (3) and its complexes with calmodulin mutants VU-1 (4) and 
VU-60 (5). The final concentration f caldesmon was 200 nM, that of 
calmodulin mutants was 400 nM (VU-1) or 800 nM (VU-60). (B) 
Titration of ealdesmon by mutant calmodulins VU- 1 (1) and VU-60 (2). 
The relative fluorescence (FIFo) was measured at322 nm. The smooth 
curve through the data points was calculated for the binding of 1 mol 
of calmodulin/mol caldesmon with K d = 65 nM and Fmax/F o= 0.86 for 
VU-1, and Kd = 1200 nM and F,n,x/F o= 0.57 for VU-60. 
120) changed to lysine residues. Moreover, this mutant induced 
only a 20% increase in caldesmon fluorescence at322 nrn and 
marginally shifted its fluorescence maximum (Table 1). As 
the common mutation in VU-40 and VU12A CaMs 
is Glul20-*Lys, it appears that caldesmon may be 
quite sensitive to electrostatic perturbation i this region of 
CaM. 
The third group of calmodulin mutants tudied were those 
with very poor interaction with caldesmon. For example, VU- 
18A calmodulin, in which negatively charged clusters in the 
central helix (EEE82-84 and DEE 118-120) were simultaneously 
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changed to lysines induced only a very small increase in cal- 
desmon fluorescence (Fmax) and only slightly blue-shifted the 
wavelength of the fluorescence maximum. Caldesmon binding 
parameters were estimated only from the titration so that the 
Kd value in Table 1 represents a lower limit of the affinity of 
caldesmon for this calmadulin. In addition to the mutant with 
dramatically altered charge, we also analyzed two mutants 
which have defects in the first (E31A-CaM, VU-60) and in the 
second (E67A-CaM, VU13) Ca2+-binding loops [25]. We found 
that both of these mutants had rather low affinity for cal- 
desmon, induced only slight blue shifts, and increased the fluo- 
rescence intensity of caldesmon to values consistently lower 
than wild-type CaM (Table 1). The calculated Kd values for 
VU-13 and VU-60, therefore, represent lower limits. All exper- 
iments with VU-13 and VU-60 mutants were performed under 
standard conditions in the presence of 0.1 mM CaC12 where 
these proteins are fully saturated by Ca 2+ [25], even in the 
absence of calmodulin binding proteins. Complete interpreta- 
tion of these results, however, will require titration of cal- 
desmon with VU-13 and VU-60 at different Ca 2÷ concentra- 
tions. Nevertheless, the data presented indicate that the 
CaZ+-binding capacity in the first and second CaZ+-binding do- 
mains of CaM dramatically affects the interaction of calmod- 
ulin with caldesmon. 
4. Discussion 
Recently published results [10] indicate that a synthetic pep- 
tide analogue of avian caldesmon (residues G651-$667) binds 
to calmodulin in an s-helical conformation. This agrees well 
with the fact that many calmodulin-binding peptides interact 
with calmodulin in the form of an amphiphillic s-helix [26]. For 
example, the amphiphillic ~-helix of a peptide analog of the 
calmodulin-binding domain of smooth muscle/non-muscle 
myosin light chain kinase (MLCK) is located in a tunnel formed 
Table 1 
Interaction of calmodulin mutants with avian gizzard caldesmon 
Name, mutation Kd (nM) (F0+Fmax)/F0 Blue shift 
of the 
maximum 
of fluor- 
escence 
(nm) 
Wild-type CaM 82 + 18 1.82 11-13 
VU-1 65 _+ 22 1.84 l0 12 
Group 1 
VU-17, S101F 101 + 23 1.77 10-12 
VU-28, E84K 80 _+ 22 1.97 11-13 
VU-65, E84Q E120Q 70 + 14 1.75 1~12 
Group 2 
VU-5, G33V 140 + 28 1.96 11-13 
VU-8, EEE82-84KKK 150 + 20 1.87 11 13 
VU-64C, del (82-84) 150 + 21 1.81 11-13 
VU-12A, DEEll8-120KKK 210 + 90 1.20 2-4 
VU-40, E84K E120K 270 + 40 1.71 5-7 
Group 3 
VU-13, E67A >400 1.48 5-7 
VU-60, E31A > 800 1.59 2-4 
VU-18A, EEE82-84KKK 
DEE118-120KKK >2000 1.24 5-7 
Ka, concentration f calmodulin-induced half-maximal increase in tryp- 
tophan fluorescence, (F0 + Fmax)/Fo, increase in the fluorescence at322 
nm induced by addition of saturating concentrations ofcalmodulin. 
by a bent calmodulin molecule [27]. Both amino-terminal nd 
carboxyl-terminal globular parts of calmodulin and its central 
s-helix are involved in the complex formation. Similar results 
were obtained with calmodulin-binding peptides based upon 
the skeletal muscle isoform of MLCK [28] and calmodulin- 
dependent protein kinase II [29]. If this model is applicable to 
caldesmon one can expect hat a number of residues located in 
different parts of the calmodulin molecule will be involved in 
caldesmon binding. 
Our data with calmodulin mutants supports this sort of 
model for caldesmon interaction i  that amino acid residues in 
both halves of CaM appear to be important for the interaction 
with caldesmon. In the carboxyl-terminal domain the nega- 
tively charged cluster DEE118-120 contributes to the interac- 
tion with caldesmon, a property shared with a number of other 
target proteins (such as Ca2+-calmodulin-dependent protein ki- 
nase II, MLCK, phosphorylase kinase and Ca-ATPase [13 
15,22,27]). This also correlates with the fact that the backbone 
amide resonances of Asp- l l8 and Val-121 of calmodulin un- 
dergo a small chemical shift after binding to a caldesmon frag- 
ment [10]. In the central helix, residues 82-84 may have differ- 
ent contributions towards interaction with caldesmon, as 
mutant E84K-CaM was nearly identical to wild-type CaM but 
the cluster mutant VU-8 (Glu82-84 ~ Lys) or deletion mutant 
VU- 64C exhibited ecreased interaction. These results differ 
from MLCK where Glu-84 is more important for interaction 
with CaM than Glu-82 or -83 [23,24]. Therefore, the sensitivity 
of caldesmon to changes in residues 82 83 of CaM may be 
similar to that of the catalytic subunit of phosphorylase kinase 
[15], which is affected by mutations at these two amino acids 
in CaM. 
The amino-terminal domain of calmodulin is also involved 
in caldesmon binding. Mutation of Gly-33 to Val (VU-5) in the 
helix following the first Ca2+-binding loop, significantly affects 
the binding of calmodulin to caldesmon. In addition, alteration 
of the first (VU-60) or of the second (VU-13) Ca2+-binding 
loops of CaM, decreased binding to caldesmon and altered 
calmodulin-induced changes in the fluorescence spectra of cal- 
desmon (Table 1). Additional experiments directed towards 
determining the Ca 2÷ occupancy of these proteins when bound 
to caldesmon may reveal how caldesmon affects Ca 2+ binding 
to CaM in the complex. Altogether the results upport models 
of caldesmon i teraction where a linear peptide segment of the 
protein, with the potential to form an amphiphillic helix, is a 
major contributor to the interaction with CaM. 
It has been proposed that caldesmon has two closely located 
calmodulin-binding sites [8,9]. The first site (residues 651-667 
of avian caldesmon) has been modeled with a synthetic peptide 
analogue, as described above, which mimics both the affinity 
and the Trp fluorescence changes observed with caldesmon 
[30], and forms an s-helix when bound to calmodulin [10]. 
However, the ability to regulate actin-activated myosin ATPase 
activity, a property of caldesmon and larger caldesmon frag- 
ments [8,9] is not found in this peptide, even though it can 
co-sediment with actin [30]. A peptide analogue of the second 
site (residues 675-695 of avian caldesmon) also has a Trp which 
undergoes spectral changes when bound to CaM [9]. Sequences 
overlapping the carboxyl-terminal end of site 2 also bind to 
F-actin and inhibit actomyosin ATPase activity [8,9]. These 
interactions could be like the allosteric ontrol that CaM exhib- 
its in binding to auto-inhibited protein kinases uch as MLCK 
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[24] and CaM-dependent protein kinase II [31]. In these sys- 
tems, the CaM binding and auto-inhibitory sequences are in 
adjacent or overlapping linear segments. If the calmodulin- 
caldesmon complex shares some features of the kinase com- 
plexes, it may be possible to invoke an allosteric ontrol of an 
actin binding site by interaction with calmodulin at a proximal 
site. If this comparison is correct, then we may suggest hat, 
while caldesmon could interact with calmodulin using elements 
of both sites, it might also allosterically modify the actin bind- 
ing properties of one site by interaction at another. This hy- 
pothesis can be experimentally verified by investigating the 
interaction of caldesmon fragments or synthetic peptides con- 
taining only one calmodulin-binding site with selected calmod- 
ulin mutants. 
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